Garlic organosulfur compounds as natural inhibitors of 5-alpha reductase for prostate health

Technology
Conceptual
University

Research exploring whether garlic-derived organosulfur compounds can inhibit 5-alpha reductase enzymes (5AR1 and 5AR2) to reduce dihydrotestosterone production, potentially benefiting benign prostatic hyperplasia. The study investigates ajoene and related compounds in mammalian cell models using LC-MS/MS steroid conversion assays.

Overview

This research investigates the potential of natural garlic organosulfur compounds, particularly ajoene and its analogues, to inhibit the catalytic activity of 5-alpha reductase type 1 (5AR1) and type 2 (5AR2). These enzymes convert testosterone to dihydrotestosterone, a hormone implicated in benign prostatic hyperplasia and prostate cancer. By blocking this conversion, garlic compounds may offer a natural approach to managing prostate health conditions, potentially serving as an alternative or complement to existing pharmaceutical treatments such as finasteride.

The research addresses an underexplored area at the intersection of natural product biochemistry and steroid metabolism. Garlic consumption has been associated with improved prostate disease parameters, yet the specific molecular mechanisms remain unclear. This work aims to identify and characterise which organosulfur compounds are responsible for these effects and how they interact with 5AR enzymes.

Technical specifications

Research approach:

  • Transient transfection of 5AR1 and 5AR2 in mammalian cell models such as HEK293 cells
  • Steroid conversion assays measuring testosterone to dihydrotestosterone conversion
  • LC-MS/MS analysis of steroid metabolites with and without natural garlic compounds
  • Testing of ajoene, diallyl disulfide, and diallyl trisulfide as potential inhibitors
  • Investigation in stromal and epithelial BPH cell models, including co-culture systems representing intact prostate tissue
  • Chemical synthesis of natural tetrasulfides for extended compound screening
  • Data normalisation to protein content and viable cell counts

Proposed mechanism of action:

  • Competitive or non-competitive inhibition of 5AR catalytic activity
  • Disruption of disulfide bridge formation between Cys5 and Cys133 critical for 5AR2 protein folding
  • S-thiolation binding to cysteine residues, similar to documented effects on STAT3 and COX2 proteins
  • Resulting misfolding and inactivation of 5AR enzymes
Technology readiness level

This research is at an early exploratory stage. The hypothesis is supported by published evidence showing that garlic extracts reduced prostate weight and DHT levels in BPH-induced animal models, and that ajoene binds covalently to cysteine residues in other proteins. However, the specific inhibitory effects of ajoene and analogues on 5AR1 and 5AR2 have not yet been directly validated.

The proposed two-year study would establish proof-of-concept through in vitro enzyme inhibition assays and cell-based models. Funding is required for LC-MS/MS analysis, tissue culture reagents, chemical synthesis of natural tetrasulfides, an automated cell counter, and key personnel. Upon completion, findings could support further development toward nutraceutical or pharmaceutical applications for prostate health.


About Stellenbosch University

Stellenbosch University is a comprehensive public research university in South Africa’s Western Cape with a strong research culture. Industry collaboration runs through Innovus, the university’s technology transfer office, and SU LaunchLab, which incubates spinouts and partner ventures. Field-scale testing uses university experimental farms at Welgevallen and Mariendahl, and clinical translation is supported by the Biomedical Research Institute on the Tygerberg medical campus alongside the teaching hospital. Research is backed by competitive national funding, including the National Research Foundation and the South African Medical Research Council. Innovus manages IP, licensing, and company formation to streamline engagement.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.